The Scientific Observer Issue 29
In clinical trials exploring psychedelic drugs for the treatment of mental illness, many patients report life-changing effects. But what happens when patients assigned to the placebo arm also report similar experiences? Issue 29 explores the power of the placebo in psychedelic trials, asking leading experts why this phenomenon occurs and what it means for the future of these drugs in clinical practice.
Also in issue 29:
- How a CRISPR-Like System Was Discovered in Eukaryotes
- Fragment-Based Drug Discovery Enters the Mainstream
- Novel Psychoactive Substances
As a thank you for downloading this issue of The Scientific Observer, you’ll receive an exclusive visual guide to the key psychedelic drugs.